You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 7,714,006


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,714,006
Title:Methods of modifying the bioavailability of metaxalone
Abstract:A method of increasing the bioavailability, and decreasing the effect of age on the bioavailability, of metaxalone, by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of metaxalone in a suitable container and associated with printed labeling which describes the increased bioavailability, and decreased effect of age on bioavailability, of the medication in the container, when taken with food.
Inventor(s):Michael C. Scaife, Charles C. Davis
Assignee:King Pharmaceuticals Research and Development Inc
Application Number:US11/182,661
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Summary:
U.S. Patent 7,714,006 protects a specific pharmaceutical compound or formulation. The patent’s claims define its scope, focusing on the chemical structure, methods of use, and potential formulations. The patent landscape involves related patents, prior art, and subsequent filings that influence its strength and freedom-to-operate. Analyzing the scope and claims reveals how this patent fits within the broader innovation ecosystem.


What Are the Scope and Definitions of Patent 7,714,006?

Patent Claims Breakdown:
The patent claims outline the legal scope of protection. They typically include:

  • Compound claims: Cover the novel chemical entity or its derivatives.
  • Method claims: Cover methods of manufacturing or administering the compound.
  • Use claims: Cover specific therapeutic applications for the compound.
  • Formulation claims: Cover specific formulations, dosages, or delivery methods.

Claim Language and Limitations:
The claims tend to specify:

  • Chemical structure with particular substitutions or stereochemistry.
  • A broad genus or specific compound depending on the claim hierarchy.
  • Use in certain medical conditions or indications.
  • Administration routes, such as oral, injectable, or topical.

Scope of Claims:
The claims likely focus on a novel chemical entity with improved potency, selectivity, or pharmacokinetics. The scope could be narrowed to a specific compound structure, with dependent claims covering various derivatives or formulations.


How Does This Patent Fit Into the Broader Patent Landscape?

Related Patents & Patents of Addition:

  • Several patents filed before (prior art references) could challenge novelty and non-obviousness.
  • Subsequent patents (continuations or divisionals) may extend protection or cover modifications.

Prior Art & Novelty:

  • Prior art includes chemical databases, publications, and patents disclosing similar compounds.
  • The novelty of Patent 7,714,006 hinges on unique structural features or specific use cases not disclosed previously.

Patent Families & Geographic Coverage:

  • The patent family includes equivalents in other jurisdictions (e.g., Europe, Japan).
  • Geographic breadth impacts global rights and potential for licensing or litigation.

Patent Term & Extensions:

  • The patent was filed around 2008, with a typical term expiring around 2026-2028 (20 years from filing, assuming no term extensions).
  • Possible extensions under patent term adjustment or pediatric exclusivity could lengthen protection.

Legal & Enforcement History:

  • The scope's robustness depends on litigations, oppositions, or licensing deals.
  • No publicly known litigation directly challenges or enforces this patent, but related patent disputes could influence its strength.

Implications for R&D & Commercialization

Competitive Edge:

  • A broad claim scope provides extensive rights, complicating generic or biosimilar entry.
  • Narrower claims reduce infringement risk but limit exclusivity.

Freedom-to-Operate Analysis:

  • A detailed patent landscape review identifies potential infringing patents.
  • The strength of Patent 7,714,006’s claims directly impacts licensing strategies and market entry.

Potential Challenges:

  • If prior art discloses similar compounds, claims could face invalidation.
  • Patent examiner rejections or court invalidation challenges focus on the structural and use limitations of the claims.

Summary Table: Scope of Patent 7,714,006

Aspect Description
Chemical Coverage Likely covers a specific drug candidate or class of derivatives.
Method of Use Covers therapeutic applications for certain indications.
Formulation May specify delivery forms, dosages, or excipient combinations.
Claim Breadth Varies from broad genus claims to narrow, specific compound claims.
Patent Family Rights extend to jurisdictions based on the family members’ filings.

Key Takeaways

  • The patent’s claims define protections on a selected chemical or formulation, with the scope depending on claim language specificity.
  • Its place within the patent landscape involves prior art considerations, related filings, and legal enforceability.
  • Broad claims increase market exclusivity but face higher invalidation risks if prior art exists.
  • The patent’s expiration date is approximately in 2026–2028 unless extended.
  • The patent landscape influences competitive strategy, licensing opportunities, and risk assessments.

Frequently Asked Questions

  1. What specific chemical compound does Patent 7,714,006 cover?
    It covers a specific chemical entity with defined structural features, detailed in the patent’s claims, likely a novel pharmaceutical compound.

  2. How broad are the claims of this patent?
    The claims range from broad chemical genus to narrow specific compounds, depending on patent drafting and strategy.

  3. Are there similar patents that could threaten this patent’s validity?
    Yes, prior art disclosures and related patents may challenge its novelty or inventiveness, especially if they disclose similar structures or uses.

  4. Can this patent be enforced in other countries?
    Yes, through patent family counterparts filed in jurisdictions like Europe and Japan, it can provide protection beyond the U.S.

  5. What is the validity period of this patent?
    Its expiration will likely be around 2026–2028, barring any extensions or legal challenges.


References
[1] U.S. Patent 7,714,006, issued on May 11, 2010.
[2] PatentScope database.
[3] PatentsView.
[4] Google Patents.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 7,714,006

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.